For
p
atients
For
r
esearch sites
Find a trial
Researchers
Sponsors
Patients
Company
Log in
Get started
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma